Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab

NCT01276379 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

221

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: FOLFIRI (m)
DRUG: FOLFOX-6 (m)
DRUG: Cetuximab

Sponsor

Grupo Espanol Multidisciplinario del Cancer Digestivo